Xu Chen
7Patents
3h-index
17Co-inventors
50Inventor score
Filing activity: May 16, 2001 → May 14, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7163789B2 | Cancer diagnosis method | Chemistry; Metallurgy | 94 | Expired |
| US9327282B2 | Diagnosis and treatment of selective catalytic reduction catalyst | Emerging Cross-Sectional Technologies | 3 | Active |
| US8822364B2 | Method for treating a platinum contaminated catalytic component | Performing Operations; Transporting | 3 | Active |
| US9051862B2 | Diagnosis and treatment of selective catalytic reduction catalyst | Emerging Cross-Sectional Technologies | 2 | Active |
| US10538237B2 | Fuel and reagent degradation reduction in hybrid electrical vehicle systems | Emerging Cross-Sectional Technologies | 0 | Active |
| US11866398B2 | Total synthesis of prostaglandin J natural products by stereoretentive metathesis | Chemistry; Metallurgy | 0 | Active |
| US8986620B2 | System for treating a platinum contaminated catalytic component | Performing Operations; Transporting | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.